検索条件
MHC Allele - A*02:01
クリップ | Code No. | 品名 | データ | ||||
---|---|---|---|---|---|---|---|
データ
シート |
項目 | 標識 | MHC Allele | 包装 | 価格 | 在庫 | |
配列 | 位置 | 温度 | |||||
|
|||||||
TB-0135-1 |
HLA-A*02:01 HIV Vif Tetramer-GLADQLIHL-PE |
||||||
virus HIV |
PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
GLADQLIHL | 101-109 | 4°C | |||||
TS-M016-2 |
T-Select HLA-A*02:01 WT1126-134 Tetramer-RMFPNAPYL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
RMFPNAPYL | 126-134 | 4°C | |||||
TS-M041-2 |
HLA-A*02:01 HCV NS4B 1992-2000 Tetramer-VLSDFKTWL-APC |
||||||
virus | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
VLSDFKTWL | 1992-2000 | 4°C | |||||
TS-M042-1 |
HLA-A*02:01 HCV NS5B 2594-2602 Tetramer-ALYDVVTKL-PE |
||||||
virus | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
ALYDVVTKL | 2594-2602 | 4°C | |||||
TS-M042-2 |
HLA-A*02:01 HCV NS5B 2594-2602 Tetramer-ALYDVVTKL-APC |
||||||
virus | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
ALYDVVTKL | 2594-2602 | 4°C | |||||
TS-M095-2 |
HLA-A*02:01 PP2A Tetramer-SLLPAIVEL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
SLLPAIVEL | 402-410 | 4°C | |||||
TB-M047-4 |
HLA-A*02:01 HPV16 E6 Tetramer-KLPQLCTEL-BV421 |
||||||
virus | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
KLPQLCTEL | 18-26 | 4°C | |||||
TB-0154-4 |
HLA-A*02:01 HHV-8 gB Tetramer-LMWYELSKI-BV421 |
||||||
virus | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
LMWYELSKI | 4°C | ||||||
TB-0120-4 |
HLA-A*02:01 gp100 Tetramer-YLEPGPVTV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YLEPGPVTV | 4°C | ||||||
TB-0016-4 |
T-Select HLA-A*02:01 Her-2/neu Tetramer-RLLQETELV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
RLLQETELV | 689-697 | 4°C | |||||
TB-0155-4 |
HLA-A*02:01 Survivin Tetramer-LTLGEFLKL-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
LTLGEFLKL | 96-104 | 4°C | |||||
TB-0155-2 |
HLA-A*02:01 Survivin Tetramer-LTLGEFLKL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
LTLGEFLKL | 96-104 | 4°C | |||||
TB-0155-1 |
HLA-A*02:01 Survivin Tetramer-LTLGEFLKL-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
LTLGEFLKL | 96-104 | 4°C | |||||
TB-0153-2 |
HLA-A*02:01 MUC1 Tetramer-LLLTVLTVV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
LLLTVLTVV | 13-21 | 4°C | |||||
TB-0169-1 |
HLA-A*02:01 BCR-ABL Tetramer-GVRGRVEEI-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
GVRGRVEEI | bcr-abl fusion protein | 4°C | |||||
TB-0164-1 |
HLA-A*02:01 EZH2 Tetramer-YMCSFLFNL-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YMCSFLFNL | 666-674 | 4°C | |||||
TB-0163-1 |
HLA-A*02:01 p53 Tetramer-YLGSYGFRL-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YLGSYGFRL | 103-111 | 4°C | |||||
TB-0161-1 |
HLA-A*02:01 PSMA Tetramer-VLAGGFFLL-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
VLAGGFFLL | 27-38 | 4°C | |||||
TB-0151-2 |
HLA-A*02:01 BA46 Tetramer-GLQHWVPEL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
GLQHWVPEL | 97-106 | 4°C | |||||
TB-0151-1 |
HLA-A*02:01 BA46 Tetramer-GLQHWVPEL-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
GLQHWVPEL | 97-106 | 4°C | |||||
TB-0136-1 |
HLA-A*02:01 p53 Tetramer-GLAPPQHLIRV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
GLAPPQHLIRV | 187-197 | 4°C | |||||
TB-0134-4 |
HLA-A*02:01 GPC3 Tetramer-FVGEFFTDV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
FVGEFFTDV | 144-152 | 4°C | |||||
TB-0134-2 |
HLA-A*02:01 GPC3 Tetramer-FVGEFFTDV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
FVGEFFTDV | 144-152 | 4°C | |||||
TB-0133-2 |
HLA-A*02:01 HTLV bZIP Tetramer-AVLDGLLSL-APC |
||||||
virus HTLV |
APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
AVLDGLLSL | 42-50 | 4°C | |||||
TB-0131-4 |
HLA-A*02:01 EBV BALF4 Tetramer-FLDKGTYTL-BV421 |
||||||
virus EBV |
BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
FLDKGTYTL | 276-284 | 4°C | |||||
TB-0131-2 |
HLA-A*02:01 EBV BALF4 Tetramer-FLDKGTYTL-APC |
||||||
virus EBV |
APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
FLDKGTYTL | 276-284 | 4°C | |||||
TB-0127-4 |
HLA-A*02:01 PSCA Tetramer-AILALLPAL-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
AILALLPAL | 105-133 | 4°C | |||||
TS-M052-2 |
HLA-A*02:01 HBV env 348-357 Tetramer-GLSPTVWLSV-APC |
||||||
virus | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
GLSPTVWLSV | 348-357 | 4°C | |||||
TS-M079-1 |
HLA-A*02:01 SSX-2 Tetramer-KASEKIFYV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
KASEKIFYV | 41-49 | 4°C | |||||
TB-0116-1 |
HLA-A*02:01 LCMV GPC 447-455 Tetramer-YLVSIFLHL-PE |
||||||
virus LCMV |
PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YLVSIFLHL | 4°C | ||||||
TB-0114-2 |
HLA-A*02:01 hTERT Tetramer-YLQVNSLQTV-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YLQVNSLQTV | 4°C | ||||||
TB-0153-1 |
HLA-A*02:01 MUC1 Tetramer-LLLTVLTVV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
LLLTVLTVV | 13-21 | 4°C | |||||
TB-0163-2 |
HLA-A*02:01 p53 Tetramer-YLGSYGFRL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YLGSYGFRL | 103-111 | 4°C | |||||
TB-0161-2 |
HLA-A*02:01 PSMA Tetramer-VLAGGFFLL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
VLAGGFFLL | 27-38 | 4°C | |||||
TB-0158-4 |
HLA-A*02:01 CD20 Tetramer-SLFLGILSV-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
SLFLGILSV | 188-196 | 4°C | |||||
TB-0134-1 |
HLA-A*02:01 GPC3 Tetramer-FVGEFFTDV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
FVGEFFTDV | 144-152 | 4°C | |||||
TB-0133-1 |
HLA-A*02:01 HTLV bZIP Tetramer-AVLDGLLSL-PE |
||||||
virus HTLV |
PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
AVLDGLLSL | 42-50 | 4°C | |||||
TB-0128-4 |
HLA-A*02:01 hTERT Tetramer-ALLTSRLRFI-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
ALLTSRLRFI | 615-624 | 4°C | |||||
TB-0128-2 |
HLA-A*02:01 hTERT Tetramer-ALLTSRLRFI-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
ALLTSRLRFI | 615-624 | 4°C | |||||
TS-M043-1 |
HLA-A*02:01 HCV NS5B 2594-2602 Tetramer-ALYDVVSKL-PE |
||||||
virus | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
ALYDVVSKL | 2594-2602 | 4°C | |||||
TB-0169-2 |
HLA-A*02:01 BCR-ABL Tetramer-GVRGRVEEI-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
GVRGRVEEI | bcr-abl fusion protein | 4°C | |||||
TB-0164-4 |
HLA-A*02:01 EZH2 Tetramer-YMCSFLFNL-BV421 |
||||||
cancer | BV421 | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
YMCSFLFNL | 666-674 | 4°C | |||||
TB-0150-2 |
HLA-A*02:01 hTERT Tetramer-GLLGASVLGL-APC |
||||||
cancer | APC | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
GLLGASVLGL | 674-683 | 4°C | |||||
TB-0128-1 |
HLA-A*02:01 hTERT Tetramer-ALLTSRLRFI-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
ALLTSRLRFI | 615-624 | 4°C | |||||
TB-0013-1 |
iTAg Tetramer/PE – HLA-A*02:01 gp100 (IMDQVPFSV) |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
IMDQVPFSV | 209-217 | 4°C | |||||
TB-0014-1 |
iTAg Tetramer/PE – HLA-A*02:01 gp100 (ITDQVPFSV) |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
ITDQVPFSV | 209-217 | 4°C | |||||
TB-M120-1 |
HLA-A*02:01 PSA 141-150 Tetramer-FLTPKKLQCV-PE |
||||||
cancer | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
FLTPKKLQCV | 141-150 | 4°C | |||||
TB-0008-1 |
iTAg Tetramer/PE – HLA-A*02:01 HIV pol (ILKEPVHGV) |
||||||
virus | PE | A*02:01 | 50 tests | ¥190,000 |
0 (お問合せ) |
||
ILKEPVHGV | 476-484 | 4°C |
※在庫につきましては2024年03月28日 17時00分時点における在庫数を表示してあります。
※価格の赤色表示につきましては、
キャンペーン価格の表示となっております。
※このサイトからは直接注文はできません。ご注意ください。
※保存温度の表記について: RT: 室温
※本サイトの掲載製品は、品質改良のため予告なく仕様などの変更、または販売中止となる場合がございます。あらかじめご了承ください。